Personalised Healthcare
& Diagnostics
One of our priorities at Roche is to improve the patient treatment pathway right from the start. Learn more about our innovations beyond medicine below:
Personalised Healthcare
Innovative technology and holistic approaches to data are providing new tools to drive better health outcomes. Browse the resources below to understand how Roche is contributing to these innovations.
PHC Oncology Video & Slide Deck
Summarising Roche’s efforts within PHC in Oncology
Explainer Video Digital Patient Monitoring and Management
Evaluating the use of Digital patient monitoring and management (DPMM) tools for patients with advanced or metastatic NSCLC treated with CIT, by Schmalz O., et al.
Personalised Healthcare in Oncology
Information about Roche’s Personalised Healthcare approach in oncology, with case study examples to illustrate key ongoing PHC oncology initiatives.
Personalised health care community hub
A collection of educational materials was made with and for the patient community. It supports advocates in their work to make personalised health solutions available for everyone, and helps those affected by health conditions to get to know the benefits that personalised healthcare can offer.
Foundation Medicine®
Foundation Medicine offers a proven portfolio of comprehensive genomic profiling products that help physicians make more informed care decisions.
FoundationOne®CDx Report Explainer
Gain a deeper understanding of the use of FoundationOne®CDx based on a Sarcoma and a Glioma Case.
CUPISCO Screening Failure Manuscript Explainer
Summary of the manuscript from Pauli C. et al. (Oncologist; 2021 May;26(5):e769-e779), highlighting the challenges in diagnosing unfavorable Cancer of Unknown Primary (CUP). By sharing this experience, the authors aim to foster understanding of diagnostic challenges and improve diagnostic pathology and clinical CUP algorithms.
NTRK Explainer Video
Describing the Pan Tumour landscape of NTRK alterations by using data from Foundation Medicine's FoundationCore® database published by Westphalen C.B. et al (NPJ Precis Oncol. 2021 Jul 20;5(1):69)
Diagnostics
Our mission is to improve the lives of all patients afflicted with cancer. As an innovator of tissue-based diagnostic solutions for patients worldwide, we provide the anatomic pathology lab with a powerful combination of instrumentation, medical value assays and digitally integrated workflow. Read more about Roche Tissue Diagnostics here
Pan-Oncology
NTRK
Digital Pathology
CRC, GYN
Lymphomas
Lung
Oncology Clinical Decision Support
NAVIFY®
NAVIFY Decision Support portfolio provides tools to empower your patient-centric and evidence-based insights, enabling more confident and personalized treatment decisions. Read more about how NAVIFY products can help you by following the links below.
NAVIFY® Decision Support portfolio
NAVIFY Decision Support portfolio video showcasing how the NAVIFY Decision Support portfolio optimizes clinical decision-making.
The Impact of a Digital Tumour Board Solution on Multidisciplinary Meetings
Dr Prime and Professor Hammer share the challenges faced by multidisciplinary teams when convening tumour boards and explain the findings on the impact of a digital tumour board solution on case preparations.
The Integration of Technology into Patient Management: Lessons Learned from the COVID-19 Pandemic
Professors Marchetti, Mercantini and Mazzuca share how the current pandemic has affected the care of their patients with cancer. Discussion focuses on how tumour boards have been impacted and the solutions they have used to maintain agile working practices, including implementation of a digital tumour board solution.